Sarah Boyce
CIK 1629383 · President and CEO · last filed 2026-03-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.99M
Companies
9
Total Filings
58
Lifetime Open-Market Net
-$33.85M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Avidity Biosciences, Inc. (RNAM) Delisted | President and CEO | 0 | — | — | $0 | 1 | 2026-02-27 |
| RNA | President and CEO | 277,000 | $12.37 | $3.43M | -$33.09M | 27 | 2026-01-23 |
| CTNM | Director | — | $11.88 | — | $0 | 2 | 2025-06-26 |
| OABIW | Director | 104,381 | $0.10 | $10.4K | $101.4K | 5 | 2024-06-21 |
| LGND | Director | 2,892 | $255.54 | $739.0K | $0 | 5 | 2022-11-03 |
| Bruker Cellular Analysis, Inc. (BLI) Delisted | Director | 1,400 | $1.20 | $1.7K | -$611.3K | 2 | 2021-05-18 |
| AKCEA THERAPEUTICS, INC. (AKCA) Delisted | President | 19,888 | — | — | -$42.8K | 4 | 2019-07-17 |
| IONS | Chief Business Officer | 11,127 | $73.28 | $815.3K | -$212.8K | 8 | 2018-01-17 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | Chief Business Officer | — | — | — | $0 | 2 | 2015-01-20 |
Recent Filings · Page 4 of 6
58 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-24 | RNA | Grant (A) | +50,000 | $0 | EDGAR |
| 2022-11-14 | OABIW | Buy (P) | +36,000 | $101.4K | EDGAR |
| 2022-11-03 | LGND | Disp (D) | −1,004 | $0 | EDGAR |
| 2022-11-03 | — | Grant (A) | +37,437 | $0 | |
| 2022-08-26 | RNA | Mixed | — | -$1.08M | EDGAR |
| 2022-08-17 | RNA | Mixed | — | -$2.1K | EDGAR |
| 2022-06-13 | LGND | Grant (A) | +1,004 | $0 | EDGAR |
| 2022-03-15 | RNA | Grant (A) | — | $0 | EDGAR |
| 2021-06-07 | LGND | Grant (A) | +630 | $0 | EDGAR |
| 2021-05-18 | Bruker Cellular Analysis, Inc. (BLI) Delisted | Grant (A) | +1,400 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.